Resume

EDUCATION

• Medicine Degree
  University of Santiago de Compostela, Spain
  10/2002-7/2008

• Bachelor’s Degree in Computer Engineering
  Open University of Catalonia, Spain
  1/2016-1/2023

• Ph.D. in Medicine
  Excellent Cum Laude and extraordinary doctorate award
  Autonomous University of Barcelona, Spain
  10/2011-11/2014

• Ph.D. in Bioinformatics
  Excellent Cum Laude and extraordinary doctorate award
  Open University of Catalonia, Spain
  6/2018-12/2020

• Internal Medicine Residency
  Vall d’Hebron University Hospital, Barcelona, Spain
  5/2009-5/2014

• Inflammatory Muscle Diseases Clinical Fellowship
  Muscle Disease Unit, NIAMS/NIH
  Bethesda, United States of America
  7/2018-1/2021

• Master of Research Methodology in Health Sciences
  Autonomous University of Barcelona, Spain
  11/2011-4/2015

• Master of Advanced Studies in Molecular Medicine
  University of Santiago de Compostela, Spain
  7/2008-9/2010

LICENSURE AND BOARD CERTIFICATION

• Medical License from the State of Maryland (licensing number D0094618)
  9/2023-Present

• Medical License from the State of New York (licensing number 314404)
  12/2021-Present

• Senior Medical Staff Accreditation at the National Institutes of Health
  7/2018-Present

• Basic Life Support, American Heart Association
  2017-Present

• Certificate of the United States Medical Licensing Examination (USMLE)
  United States of America and the Educational Commission for Foreign
  Medical Graduates (ECFMG certificate number 0-965-550-7)
  5/2015-5/2017

• Medical License from the Official College of Doctors of Barcelona
  (licensing number 080844846)
  5/2009-Present

PROFESSIONAL EXPERIENCE

• Associate Research Physician
  Muscle Disease Section
  NIAMS/NIH
  Bethesda, United States of America
  5/2024-Present

• Staff Clinician
  Muscle Disease Unit
  NIAMS/NIH
  Bethesda, United States of America
  1/2021-Present

• Assistant Professor
  Faculty of Computer Science, Multimedia and Telecommunications
  Open University of Catalonia
  Barcelona, Spain
  3/2019-Present

• Clinical Fellow
  Muscle Disease Unit
  NIAMS/NIH
  Bethesda, United States of America
  7/2018-1/2021

• Adjunct Assistant Professor
  Department of Neurology
  Johns Hopkins University
  Baltimore, United States of America
  11/2017-Present

• Visiting Fellow
  Muscle Disease Unit
  NIAMS/NIH
  Bethesda, United States of America
  6/2015-6/2018

• Myositis Association Research Fellow
  Muscle Disease Unit
  NIAMS/NIH
  Bethesda, United States of America
  10/2016-6/2018

• Postdoctoral Fellow
  Vall d’Hebron Research Institute
  Autoimmune Systemic Diseases Unit
  Vall d’Hebron University Hospital
  Barcelona, Spain
  1/2015-6/2015

• Attending Physician
  Internal Medicine Department
  Sant Rafael Hospital
  Barcelona, Spain
  5/2014-4/2015

• Attending Physician
  Internal Medicine Department
  Quiron Dexeus University Hospital
  Barcelona, Spain
  5/2014-11/2014

• Research Fellow
  Myositis Center
  Johns Hopkins Hospital
  Baltimore, United States of America
  10/2013-12/2013

• Internal Medicine Fellow
  Department of Internal Medicine
  Autoimmune Systemic Diseases Unit
  Vall d’Hebron University Hospital
  Barcelona, Spain
  5/2009-5/2014

• Postgraduate Fellow
  Thyroid and Metabolic Diseases Unit
  University of Santiago de Compostela
  Santiago de Compostela, Spain
  10/2008-9/2010

• Research Student
  Thyroid and Metabolic Diseases Unit
  University of Santiago de Compostela
  Santiago de Compostela, Spain
  9/2006-9/2008

TEACHING

• Assistant Professor Data Science Master’s Degree
  Faculty of Computer Science, Multimedia and Telecommunications
  Open University of Catalonia
  Barcelona, Spain
  9/2019-Present

• Associate Professor accreditation of the National Agency for Quality Assessment and Accreditation of Spain (ANECA)
  1/2018

• Ph.D. Director of Marcelo Alvarado-Cardenas with the project: Statins and autoimmunity. Detection methods and importance of anti-HMGCR autoantibodies.
  Medicine Department
  Autonomous University of Barcelona
  Barcelona, Spain 7/2017-10/2018

• Associate Professor
  Pathophysiology and Clinical Semiology
  Medicine Department
  Autonomous University of Barcelona
  Barcelona, Spain
  9/2014-9/2015

PUBLICATIONS

Original research

1. Pinal-Fernandez I*, Munoz-Braceras S*, Casal-Dominguez M, et al. Pathological autoantibody internalisation in myositis. Ann Rheum Dis 2024.

2. Burbelo P, Huapaya JA, Khavandgar Z, Beach M, Pinal-Fernandez I, et al. Quantification of Autoantibodies Using a Luminescent Profiling Method in Autoimmune Interstitial Lung Diseases. Frontiers in Immunology 2024.

3. Najjar R, Alessi H, Pinal-Fernandez I, et al. Distinct transcript-level expression profiles and unique alternative splicing in inflammatory myopathies. ACR Open Rheumatology 2024.

4. Abad C, Pinal-Fernandez I, Guillou C, et al. IFN\(\gamma\) causes mitochondrial dysfunction and oxidative stress in myositis. Nature Communications 2024

5. Fernandez-Codina A, Nevskaya T, Baron M, …, Pinal-Fernandez I, Janet E Pope. Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trial. Rheumatology 2024.

6. Torres-Ruiz J*, Pinal-Fernandez I*, Selva-O’Callaghan A*, Cambpell B*, et al. Nailfold capillaroscopy findings of a multicentric multiethnic cohort of patients with idiopathic inflammatory myopathies. Clin Exp Rheum 2024.

7. Sherman MA, Noroozi Farhadi P, Pak K, et al. Myositis-associated autoantibodies in juvenile myositis are associated with refractory disease and mortality. Arthritis and Rheumatology 2024. As a member of the Childhood Myositis Heterogeneity Collaborative Study Group.

8. Nath A, Walitt B, …, Pinal-Fernandez I, et al. Deep phenotyping of Post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Nature Communications 2024.

9. Kleefeld F, Horvath R, Pinal-Fernandez I, et al. Multi-level profiling unravels mitochondrial dysfunction in Myotonic Dystrophy type 2. Acta Neuropathologica 2023.

10. Sherman M, Yang Q, Gutierrez-Alamillo L, et al. Clinical features and immunogenetic risk factors associated with additional autoantibodies in anti-TIF1\(\gamma\) juvenile-onset dermatomyositis. Arthritis and Rheumatology 2023. As a member of the Childhood Myositis Heterogeneity Collaborative Study Group.

11. Muñoz-Braceras S, Pinal-Fernandez I, Casal-Dominguez M, et al. Identification of unique microRNA profiles in different types of idiopathic inflammatory myopathy. Cells 2023.

12. Lopez-Guerra N*, Matas-Garcia A*, …, Pinal-Fernandez I^#, Milisenda JC^#. Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature. Autoimmun Rev 2023.

13. Pinal-Fernandez I*, Milisenda JC*, Pak K*, Munoz-Braceras S*, et al. Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. Ann Rheum Dis 2023.

14. Sherman MA, Pak K, Pinal-Fernandez I, et al. Anti-Sp4 autoantibodies co-occur with anti-TIF1 and are associated with distinct clinical features and immunogenetic risk factors in juvenile myositis. Arthritis Rheumatol 2023.

15. Pinal-Fernandez I*, Quintana A*, Milisenda JC*, Casal-Dominguez M*, et al. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor-induced myositis. Ann Rheum Dis 2023.

16. Nascimiento A, Bruels CC, Donkervoort S, …, Pinal-Fernandez I, et al. Variants in DTNA cause a mild, dominantly inherited muscular dystrophy. Acta Neuropathologica 2023.

17. Casal-Dominguez M*, Pinal-Fernandez*, Pak K, et al. Coordinated local RNA overexpression of complement induced by interferon gamma in myositis. Scientific Reports 2023.

18. Milisenda JC*, Pinal-Fernandez I*, Lloyd T, et al. The Pattern of MHC Class I Expression in Muscle Biopsies from Patients with Myositis and other Neuromuscular Disorders. Rheumatology 2023.

19. Mammen AL, Amato AA, Dimachkie MM, Chinoy H, Hussain Y, Lilleker JB, Pinal-Fernandez I, et al. Zilucoplan in immune-mediated necrotizing myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial. Lancet Rheumatology 2022.

20. Michelle EH*, Pinal-Fernandez I*, Casal-Dominguez M*, et al. Clinical subgroups and factors associated with progression in patients with inclusion body myositis. Neurology 2023.

21. Hosono Y*, Sie B*, Pinal-Fernandez I*, Pak K*, et al. Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in dermatomyositis patients with anti-TIF1\(\gamma\) autoantibodies. Ann Rheum Dis 2023.

22. Sherman MA, Graf R, Sabbagh SE, Galindo-Feria AS, Pinal-Fernandez I, et al. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not severe disease features. Rheumatology 2022.

23. Lehky T, Pinal-Fernandez I, Krakow EF, et al. Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation Survivors. Cell Ther Transplant 2022.

24. Cuvelier GDE, Schoettler M, Buxbaum N, Pinal-Fernandez I, et al. Towards a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force. Transplantation and Cellular Therapy 2022.

25. Ikenaga C, Date H, Kanagawa M, Mitsui J, Ishiura H, Yoshimura J, Pinal-Fernandez I, et al. Muscle transcriptomics shows overexpression of CDH1 in inclusion body myositis. Ann Neurol 2022.

26. Trallero-Araguas E, Gil-Vila A, Martinez-Gomez X, Pinal-Fernandez I, et al. Cancer screening in idiopathic inflammatory myopathies: ten years experience from a single center. Semin Arthritis Rheum 2022.

27. Britson K, Ling JP, Braunstein K, Montagne JM, Kastenschmidt JM, Wilson A, Ikenaga C, Tsao W, Pinal-Fernandez I, et al. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis. Sci Transl Med 2021.

28. Amici DR, Pinal-Fernandez I, Christopher-Stine L, Mammen AL, Mendillo ML. A network of core and subtype-specific gene expression programs in myositis. Acta Neuropathol 2021.

29. Casal-Dominguez M*, Pinal-Fernandez I*, Pak K, Huang W, Selva-O’Callaghan A, et al. Performance of the 2017 EULAR/ACR classification criteria for inflammatory myopathies in patients with myositis-specific autoantibodies. Arthritis Rheumatol 2021.

30. Pinal-Fernandez I*, Pak K*, Gil-Vila A*, Baucells A*, Plotz B*, et al. Anti-cortactin autoantibodies are associated with key clinical features in adult myositis but are rarely present in juvenile myositis. Arthritis Rheumatol 2021.

31. Sempere-González A, Llaneras-Artigues, Pinal-Fernandez I, et al. Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients. Med Clin (Barc) 2021.

32. Casal-Dominguez M, Pinal-Fernandez I, Derfoul A, et al. The phenotype of myositis patients with anti-Ku autoantibodies. Seminars in Arthritis and Rheumatism 2021.

33. Sabbagh SE*, Pinal-Fernandez I*, Casal-Dominguez M, et al. Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis. Clinical Rheumatology 2021.

34. Orozco-Galvez O, Fernandez-Codina A, Pinal-Fernandez I, Martinez-Valle F, Simo-Perdigo M. Response to treatment in IgG4-related disease assessed by quantitative positron emission tomography-computerized tomography scan. Clinical Nuclear Medicine 2020.

35. Montagne JM, Zheng XA, Pinal-Fernandez I, et al. Ultra-Efficient Short Read Sequencing of Immune Receptor Repertoires. EBioMedicine 2020.

36. Sabbagh S, Neely J, Chow A, DeGuzman M, Lai J, Lvovich S, McGrath T, Pereira M, Pinal-Fernandez I, et al. Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America. Rheumatology (Oxford) 2020.

37. Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, et al. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis. Ann Rheum Dis 2020;79:1234-42.

38. Casal-Dominguez M*, Pinal-Fernandez I*, Pak K, et al. The indirect immunofluorescence assay autoantibody profiles of myositis patients without known myositis-specific autoantibodies. Clin Exp Rheum 2020.

39. Milisenda JC*, Pinal-Fernandez I*, Lloyd T, et al. Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies. Clin Exp Rheum 2020.

40. Fernandez-Codina A, Pinilla B, Pinal-Fernandez I, et al. Performance of the 2019 ACR/EULAR classification criteria for IgG4-RD and clinical phenotypes in a Spanish multicenter registry (REERIGG4). Rheumatology (Oxford) 2020.

41. Romero-Bueno F, Diaz del Campo P, Trallero-Araguás E, Ruiz-Rodríguez JC, Castellvi I, Rodriguez-Nieto MJ, Martínez-Becerra MJ, Sanchez-Pernaute O, Pinal-Fernandez I, et al. Recommendations for the Treatment of Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. Semin Arthritis Rheum 2020;50:776-90.

42. Seto N, Torres-Ruiz JJ, Carmona-Rivera C, Pinal-Fernandez I, et al. Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies. JCI Insight 2020;5.

43. Parks C*, Pak K*, Pinal-Fernandez I*, et al. Trim33 (Tif1\(\gamma\)) is not required for skeletal muscle development or regeneration but suppresses cholecystokinin expression. Sci Rep 2019;9:18507.

44. Mecoli CA, Albayda J, Tiniakou E, Paik JJ, Zahid U, Danoff SK, Casciola-Rosen L, Casal-Dominguez M, Pak K, Pinal-Fernandez I, et al. Myositis Autoantibodies: A Comparison of Results from the Oklahoma Medical Research Foundation Myositis Panel to the Euroimmun Research Line Blot. Arthritis Rheumatol 2020;72:192-4.

45. Milisenda JC, Garcia AM, Jou C, Pinal-Fernandez I, et al. Sporadic inclusion body myositis: Diagnostic value of p62 immunostaining. Med Clin (Barc) 2019;153:437-40.

46. Huapaya J, Silhan L, Pinal-Fernandez I, et al. Long-term treatment with azathioprine and mycophenolate mofetil for myositis-related interstitial lung disease. Chest 2019;156:896-906.

47. Pinal-Fernandez I*, Mecoli C*, Casal-Dominguez M*, et al. More prominent muscle involvement in those dermatomyositis patients with anti-Mi2 autoantibodies. Neurology 2019;93:e1768-e77.

48. Huapaya JA, Hallowell R, Silhan L, Pinal-Fernandez I, et al. Long-term treatment with human Immunoglobulin for antisynthetase syndrome-associated interstitial lung disease. Respir Med 2019;154:6-11.

49. Pinal-Fernandez I*, Pak K*, Casal-Dominguez M*, Hosono Y, Mecoli C, Christopher-Stine L, Mammen AL. Validation of anti-Mi2 autoantibody testing by line blot. Autoimmun Rev 2020;19:102425.

50. Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, et al. Identification of distinctive interferon gene signatures in different types of myositis. Neurology 2019;93:e1193-e204.

51. Sabbagh S*, Pinal-Fernandez I*, Kishi T, et al. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis 2019;78:988-95.

52. Casal-Dominguez M*, Pinal-Fernandez I*, Huapaya J, et al. Efficacy and adverse effects of methotrexate compared with azathioprine in the Antisynthetase Syndrome. Clin Exp Rheumatol 2019;37:858-61.

53. Pinal-Fernandez I*, Amici DR*, Parks CA, Derfoul A, et al. Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity. Arthritis Rheumatol 2019;71:1371-6.

54. Brusca RM, Pinal-Fernandez I, Psoter K, et al. The ILD-GAP Risk Prediction Model Performs Poorly in Myositis-Associated Interstitial Lung Disease. Respir Med. 2019;150:63-5.

55. Randazzo D, Khalique U, Belanto J, Kenea A, Talsness DM, Olthoff JTJ, Tran MD, Zaal KJ, Pak K, Pinal-Fernandez I, et al. Persistent upregulation of the \(\beta\)-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle. Hum Mol Genet. 2019;28(7):1117-35.

56. Milisenda JC*, Collado MV*, Pinal-Fernandez I*, et al. Correlation between quantitative and semiquantitative magnetic resonance imaging and histopathology findings in dermatomyositis. Clin Exp Rheumatol 2019;37:633-40.

57. Casal-Dominguez M*, Pinal-Fernandez I*, Corse A, et al. Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies. Neurology. 2019;92(13):e1416-e26.

58. Amici DR*, Pinal-Fernandez I*, Pagkatipunan R, et al. Muscle endurance deficits in myositis patients despite normal manual muscle testing scores. Muscle Nerve. 2019;59(1):70-5.

59. De Lorenzo R*, Pinal-Fernandez I*, Huang W, et al. Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies. Neurology. 2018;90(23):e2068-e76.

60. Fernandez-Codina A, Pinilla B, Pinal-Fernandez I, et al. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index. Joint Bone Spine. 2018;85(6):721-6.

61. Yeker RM*, Pinal-Fernandez I*, Kishi T, et al. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2018;77(5):714-9.

62. Redondo-Benito A, Curran A, Villar-Gomez A, Trallero-Araguas E, Fernandez-Codina A, Pinal-Fernandez I, Rodrigo-Pendas JA, Selva-O’Callaghan A. Opportunistic infections in patients with idiopathic inflammatory myopathies. Int J Rheum Dis. 2018;21:487-96.

63. Pinal-Fernandez I, Ferrer-Fabregas B, Trallero-Araguas E, Balada E, Martinez MA, Milisenda JC, et al. Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis. Rheumatology (Oxford). 2018;57:388-96.

64. Suarez-Calvet X, Gallardo E, Pinal-Fernandez I, et al. RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis. Arthritis Res Ther. 2017;19(1):174.

65. Pinal-Fernandez I*, Casal-Dominguez M*, Huapaya JA*, et al. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. Rheumatology (Oxford). 2017;56(6):999-1007.

66. Amici DR, Pinal-Fernandez I, Mazala DA, et al. Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis. Acta Neuropathol Commun. 2017;5(1):24.

67. Fernandez-Codina A, Berastegui C, Pinal-Fernandez I, et al. Lung transplantation in systemic sclerosis: A single center cohort study. Joint Bone Spine. 2018;85(1):79-84.

68. Lloyd TE, Pinal-Fernandez I, Michelle EH, et al. Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients. Neurology. 2017;88(15):1454-60.

69. Casal-Dominguez M*, Pinal-Fernandez I*, Mego M, et al. High-resolution manometry in patients with idiopathic inflammatory myopathy: Elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset. Muscle Nerve. 2017;56:386-92.

70. Escola-Verge L, Pinal-Fernandez I, Fernandez-Codina A, et al. Mixed Connective Tissue Disease and Epitope Spreading: An Historical Cohort Study. J Clin Rheumatol. 2017;23(3):155-9.

71. Albayda J*, Pinal-Fernandez I*, Huang W, et al. Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients. Arthritis Care Res (Hoboken). 2017;69:1771-6.

72. Tiniakou E*, Pinal-Fernandez I*, Lloyd TE, et al. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford). 2017;56(5):787-94.

73. Pinal-Fernandez I*, Casal-Dominguez M*, Carrino JA, et al. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis. 2016;76(4):681-7.

74. Alvarado-Cardenas M, Marin-Sanchez A, Martinez MA, Martinez-Martinez L, Pinal-Fernandez I, Labrador-Horrillo M, et al. Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories. Autoimmun Rev. 2016;15(12):1161-6.

75. Martinez-Valle F, Fernandez-Codina A, Pinal-Fernandez I, Orozco-Galvez O, Vilardell-Tarres M. IgG4-related disease: Evidence from six recent cohorts. Autoimmunity Reviews. 2017;16(2):168-72.

76. Basharat P, Lahouti AH, Paik JJ, Albayda J, Pinal-Fernandez I, Bichile T, Lloyd TE, Danoff SK, Casciola-Rosen L, Mammen AL, Christopher-Stine L. Statin-Induced Anti-HMGCR-Associated Myopathy. J Am Coll Cardiol. 2016;68(2):234-5.

77. Johnson C, Pinal-Fernandez I, Parikh R, et al. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease. Lung. 2016;194(5):733-7.

78. Pinal-Fernandez I*, Parks C*, Werner JL, et al. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle. Arthritis Care Res (Hoboken). 2017;69(2):263-70.

79. Pinal-Fernandez I, Pineda-Sanchez V, Pallisa-Nunez E, et al. Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis. Clinical Rheumatology. 2016(9);35:2339-45.

80. Lloyd TE, Christopher-Stine L, Pinal-Fernandez I, et al. Cytosolic 5’-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases. Arthritis Care Res (Hoboken). 2016;68(1):66-71.

81. Fernandez-Codina A, Simeon-Aznar CP, Pinal-Fernandez I, et al. Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival. Rheumatol Int. 2017;37(1):75-84.

82. Pinal-Fernandez I, Pallisa-Nunez E, Selva-O’Callaghan A, et al. Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome. Clin Exp Rheumatol. 2015;33:S136-41.

83. Pinal-Fernandez I, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL. The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis. J Rheumatol. 2015;42(8):1448-54.

84. Pinal Fernandez I, Pallisa Nunez E, Selva-O’Callaghan A, Castella-Fierro E, Martinez-Gomez X, Vilardell-Tarres M. Correlation of ultrasound B-lines with high-resolution computed tomography in antisynthetase syndrome. Clin Exp Rheumatol. 2014;32(3):404-7.

85. Pinal-Fernandez I, Selva-O’Callaghan A, Fernandez-Codina A, et al. "Pregnancy in adult-onset idiopathic inflammatory myopathy": report from a cohort of myositis patients from a single center. Semin Arthritis Rheum. 2014;44(2):234-40.

86. Armadans-Tremolosa I, Selva-O’Callaghan A, Visauta-Vinacua B, Guilera G, Pinal-Fernandez I, Vilardell-Tarres M. Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy. Clin Rheumatol. 2014; 33(8):1119-25.

87. Pinal-Fernandez I, Martin-Pastor M, Ferro-Gallego P, Dominguez-Gerpe L. Ex vivo proton NMR analysis and characterization of thymus lipid metabolites and their variation with age in C57BL/6 mice. Curr Aging Sci. 2011;4(1):57-69.

Review articles

1. Selva-O’Callaghan A, Trallero-Araguas E, Gil-Vila A, …, Pinal-Fernandez I. Treatment and Monitoring of eosinophilic Fasciitis. Current Treatment Options in Rheumatology 2024.

2. Musai J, Mammen AL, and Pinal-Fernandez I. Recent Updates on the Pathogenesis of Inflammatory Myopathies. Curr Rheumatol Rep 2024.

3. Beecher G, Pinal-Fernandez I, Mammen AL, et al. Immune Checkpoint Inhibitor Myopathy: The Double-Edged Sword of Cance Immunotherapy. Neurology 2024.

4. Jammal C, Pinal-Fernandez I, Mammen AL. Adult inflammatory myopathies: updates on classification and management. Practica Neurology 2024.

5. Sevim E., Kobrin D, Casal-Dominguez M, Pinal-Fernandez I. Comprehensive Review of Dermatomyositis Treatments - From Rediscovered Classics to Promising Horizons. Expert Review of Clinical Immunology 2023.

6. Selva-O’Callaghan A, Guillen-del-Castillo A, …, Pinal-Fernandez I, Simeon-Aznar C. Systemic Sclerosis-Associated Myopathy: How to Treat. Current Treatment Options in Rheumatology 2023.

7. Ogbonnaya-Whittlesey SA, Kobrin D, Casal-Dominguez M, Mammen AL Pinal-Fernandez I. Treatment of Immune-Mediated Necrotizing Myopathy. Current Treatment Options in Rheumatology 2023.

8. Casal-Dominguez M, Pinal-Fernandez I, Mammen AL. Utility of Myositis-Specific Autoantibodies for Treatment Selection in Myositis. Current Treatment Options in Rheumatology 2022.

9. Casal-Dominguez M*, Pinal-Fernandez I*, Mammen AL. Inhibitin interferon pathways in dermatomyositis: rationale and preliminary evidence. Current Treatment Options in Rheumatology 2021.

10. Selva-O’Callaghan A, Romero-Bueno F, Trallero-Araguas E, Gil-Vila A Ruiz-Rodriguez JC, Sanchez-Pernaute O, Pinal-Fernandez I. Pharmacologic treatment of anti-MDA5 rapidly progressive interstitial lung disease. Current Treatment Options i Rheumatology 2021.

11. Selva-O’Callaghan A, Gil-Vila A, Simó-Perdigó M, Trallero-Araguás E Alvarado-Cárdenas M, Pinal-Fernandez I. PET Scan: Nuclear Medicine Imaging in Myositis. Curr Rheumatol Rep 2019;21:64.

12. Selva-O’Callaghan A, Gil-Vila A, Trallero-Araguás E Pinal-Fernandez I. Malignancy and Myositis, from Molecular Mimicry to Tumor Infiltrating Lymphocytes. Neuromuscul Disor 2019;29:819-25.

13. Selva-O’Callaghan A, Pinal-Fernandez I, Trallero-Araguas E Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurolog 2018;17:816-28.

14. Pinal-Fernandez I, Mammen AL. Dermatomyositis etiopathogenesis: A rebel soldier in the muscle. Curr Opin Rheumatol 2018;30:623-9.

15. Selva-O’Callaghan A, Martinez-Gomez X, Trallero-Araguas E, Pinal-Fernandez I. The diagnostic work-up of cancer-associated myositis. Curr Opin Rheumatol. 2018;30(6):630-6.

16. Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-Mediated Necrotizing Myopathy. Curr Rheumatol Rep. 2018;20(4):21.

17. Selva-O’Callaghan A, Alvarado-Cardenas M, Pinal-Fernandez I, et al. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations. Expert Rev Clin Immunol. 2018:1-10.

18. Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Statins: pros and cons. Med Clin (Barc). 2018;150:398-402.

19. Casal-Dominguez M, Pinal-Fernandez I, Selva-O’Callaghan A. Protocol for dyspnea in inflammatory myopathies. Medicine. 2017;12(29):1729-34.

20. Pinal-Fernandez I, Mammen AL. Spectrum of immune-mediated necrotizing myopathies and their treatments. Curr Opin Rheumatol. 2016;28(6):619-24.

21. Selva-O’Callaghan A, Trallero-Araguas E, Martinez MA, Labrador-Horrillo M, Pinal-Fernandez I, Grau-Junyent JM, et al. Inflammatory myopathy: diagnosis and clinical course, specific clinical scenarios and new complementary tools. Expert Rev Clin Immunol. 2015;11(6):737-47.

22. Selva-O’Callaghan A, Alvarado-Cardenas M, Marin A, Pinal-Fernandez I. Statins and myositis: the role of anti-HMGCR antibodies. Expert Rev Clin Immunol. 2015;11(12):1277-9.

23. Casal Domínguez M, Pinal-Fernandez I. [Guidelines for type 2 diabetes mellitus]. Archivos de Medicina. 2014;10(2);1-18.

24. Pinal-Fernandez I, Selva-O’Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev. 2014;13(4-5):379-82.

Case reports

1. Pinal-Fernandez I, Kroodsma CT, Mammen AL. Successful treatment of refractory mechanic’s hands with ustekinumab in a patient with the antisynthetase syndrome. Rheumatology (Oxford) 2019;58:1307-8.

2. Pinal-Fernandez I, Fonollosa-Pla V, Selva-O’Callaghan A. Improvement of the nailfold capillaroscopy after immunosuppressive treatment in polymyositis. QJM. 2016;109(3):205-6.

3. Pinal-Fernandez I, Garrigasait Vilaseca V, Fernandez-Codina A, Aranda Rodriguez S. [Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome]. Medicina (B Aires). 2014;74(6):474-5.

4. Pinal-Fernandez I, Callejas-Moraga EL, Roade-Tato ML, Simeon-Aznar CP. Groove sign in eosinophilic fasciitis. Lancet. 2014;384(9956):1774.

5. Callejas Moraga EL, Pinal Fernandez I, Roade Tato L, Santafe Colomina M. [Littoral cell angioma. An uncommon cause of constitutional syndrome]. Med Clin (Barc). 2015;144(5):239.

6. Pinal-Fernandez I, Solans-Laque R. The ‘sparing phenomenon’ of purpuric rash over tattooed skin. Dermatology. 2014;228(1):27-30.

7. Pinal-Fernandez I, Miranda-Barrio B. Giant aortic aneurysm in Marfan syndrome. QJM. 2014;107(2):155.

8. Pinal Fernandez I, Moris Felgueroso M, Trallero Araguas E. [Lanthanum carbonate abdominal foreign bodies]. Med Clin (Barc). 2014;142(9):426.

9. Fernandez-Codina A, Aleman C, Simon-Talero M, Salcedo-Allende MT, Pinal-Fernandez I, Segura-Garcia A. Sarcoidosis with complications. Intern Emerg Med. 2014;9(7):817-8.

10. Pinal-Fernandez I, Ferrer Fabrega B, Ramentol Sintas M, Solans Laque R. Histiocytoid Sweet syndrome and cutaneous polyarteritis nodosa secondary to myelodysplastic syndrome. Int J Rheum Dis. 2013;16(6):777-9.

11. Pinal Fernandez I, Borras A, Mejia E. [Chest pain of 48 hours of evolution in a 41 years-old man]. Med Clin (Barc). 2013;141(9):390-6.

12. Andres Cordon JF, Pinal Fernandez I, Willekens Morales R, Arderiu Freixa MA. [Recurrent pleural effusion and marked elevation of CA-125 in a patient with pseudo-Meigs’ syndrome secondary to a struma ovarii]. Med Clin (Barc). 2013;140(5):237.

13. Portela M, Pinal L, Olga S, Dalama B. Diabetes insipidus as an atypical presentation of acute myeloid leukemia. Endocrinol Nutr. 2012;59(8):516-7.

14. Pinal Fernandez I, Segura Garcia A. [Intrapulmonary solitary fibrous tumor]. Med Clin (Barc). 2012;139(6):276.

15. Pinal-Fernandez I, Segura-Garcia A. [Tolvaptan in antidiuretic hormone secretion syndrome secondary to treatment with citalopram]. Rev Clin Esp. 2011;211(9):491-2.

16. Pinal Fernandez I, Molina Romero I, Sulleiro Igual E, Segura Garcia A. [Massive eosinophilia and cholestatic hepatitis due to Strongyloides stercoralis infection]. Rev Clin Esp. 2011;211(6):e34-6.

17. Pinal-Fernandez I. [Humoral hypercalcemia in mixed endometrial carcinoma]. An Sist Sanit Navar. 2010;33(2):217-9.

Editorials

1. Pinal-Fernandez I, Greenberg S. Type I Interferons in Dermatomyositis Myoblasts: Toxic Effect and a Potential Autocrine Loop. Neurology 2022.

2. Pinal-Fernandez I, Mammen AL. Amyloid-PET: a new tool for diagnosing IBM. Nat Rev Rheumatol 2019;15:321-2.

Letters, correspondence

1. Fernandez-Codina A, Nevskaya T, Baron M, …, Pinal-Fernandez I, Janet E Pope. Brentuximab vedotin compared to historical controls for severe skin involvement in cutaneous systemic sclerosis. Rheumatology 2024.

2. Johnson C, Schiffenbauer AI, Perin J, et al. HLA Alleles Associated with Interstitial Lung Disease in North Americans with Idiopathic Inflammatory Myopathy. Am J Respir Crit Care Med 2022. As a member of the Myositis-ILD Study Group.

3. Mammen A, Pinal-Fernandez I, Rider L. Conflicting reports of anti-NT5C1a autoantibodies in juvenile myositis: Comment on the article by Rietveld et al. Arthritis Rheumatol 2021.

4. Pinal-Fernandez I, Mammen AL. Myositis-specific autoantibodies as relevant adjusting variables in myositis research. Correspondence to “From diagnosis to prognosis: Revisiting the meaning of muscle ISG15 overexpression in juvenile inflammatory myopathies” by Hou et al. Arthritis Rheumatol 2021.

5. Pinal-Fernandez I, Casal-Dominguez M, Milisenda JC, Mammen AL. Response to: Correspondence on ‘Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis’ by Takanashi et al. Ann Rheum Dis 2021.

6. Pinal-Fernandez I, Mammen AL. Case 22-2019: A 65-Year-Old Woman with Myopathy. N Engl J Med 2019;381:1693-4.

7. Pinal-Fernandez I, Mammen AL. On using machine learning algorithms to define clinically meaningful patient subgroups. Ann Rheum Dis 2019.

8. Pinal-Fernandez I, Pak K, Huang W, Mammen AL. Reply to: Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes. Medicine (Baltimore) 2015.

9. Selva-O’Callaghan A, Labirua-Iturburu A, Pinal-Fernandez I. Antisynthetase Antibodies in World Trade Center Rescue and Recovery Workers With Inflammatory Myositis: Comment on the Article by Webber et al. Arthritis Rheumatol. 2015;67:2791.

Book chapters

1. Selva-O’Callaghan A, Pinal-Fernandez I, Trallero-Araguas E, Gil-Vila A. Chapter 37: Eosinophilic fasciitis. Autoimmune Disease Diagnosis. Systemic and Organ-specific Diseases. 2nd ed: Springer Nature Switzerland; 2025:271-275.

2. Selva-O’Callaghan A, Trallero-Araguás E, Pinal Fernandez I. Chapter 25: Cancer-Associated Myositis. Managing Myositis. A Practical Guide. Springer Nature Switzerland; 2020.

3. Casal-Dominguez M, Pinal Fernandez I, A Selva-O´Callaghan. [Chapter 3: Myositis and the lung. Antisynthetase autoantibodies syndrome]. [Advances in inflammatory myopathies]. 1st ed: Marge Books; 2017.

4. Selva O’Callaghan A, Pinal Fernandez I. [Chapter 13: Journal choice] In: Jimenez Villa J, Amartin Zurro A, Argimon Pallas JM, Vilardell Tarres M, eds. [Biomedical scientific publication]. 2nd ed: Elsevier; 2015:213-22.

5. Pinal Fernandez I, Casal Dominguez M. [Non-biological immunosuppresive drugs] In: CreateSpace, ed. Wikimecum. 1st ed: Internet Medical Publishing; 2015.

6. Casal Dominguez M, Pinal Fernandez I. [Guidelines for type 2 diabetes mellitus]. 1st ed: Internet Medical Publishing; 2015.

7. Pinal Fernandez I. [Pulmonary embolism] In: CreateSpace, ed. AEMIR emergencies guidebook. 3th ed: Internet Medical Publishing; 2012.

*Co-first authors

^#Co-last authors

ORAL PRESENTATIONS

1. Pathogenic autoantibody internalization in myositis. Grand Rounds, Department of Neurology, University of Massachusetts Medical School, 2024.

2. Inlammatory myopathies highlights 2023-2024. Meeting of the Spanish group of autoimmune systemic diseases (GEAS) 2024.

3. Autoantibodies: From Bench to Bedside and Back Again. 2024 International Annual Patient Conference of the Myositis Association.

4. Pathogenic autoantibody internalization in myositis. 15e Journée Interdisciplinaire du Muscle Inflammatoire (JIMI) 2024.

5. Myositis Overview. Joint Georgetown – NIAMS Lecture series 2024.

6. Non-invasive biopsies and MRI imaging in cGVHD myofasciitis. Cutaneous Chronic GVHD Task Force Planning Meeting 2024.

7. Pathogenic autoantibody internalization in myositis. NIAMS Grand Rounds 2024.

8. Transcriptomic Signatures of Human Muscle Tissue. 5th Global Conference on Myositis 2024.

9. Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. ACR 2023.

10. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor-induced myositis. Environmental Autoimmunity Group meeting 2023.

11. Transcriptional derepression in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. The Brain Conference 2023.

12. Deconvoluting phenotypic complexity in myositis: from syndromes to diseases. 23rd Annual Neuromuscular Study Group Scientific Meeting 2022.

13. Transcriptomic analysis in myositis: deconvoluting phenotypic complexity. 13^th International Congress on Autoimmunity 2022.

14. The transcriptomic profile of muscle biopsies from patients with immune checkpoint inhibitor-induced myopathy: specific overexpression of the IL6 pathway and increase of IFNG-stimulated genes. 4th Global Conference on Myositis 2022.

15. The transcriptomic profile of muscle biopsies from patients with immune checkpoint inhibitor-induced myopathy. NIAMS IRP Scientific Retreat 2022.

16. JAK inhibitors in dermatomyositis. 2022 NIH Neuromuscular Journal Club.

17. From syndromes to diseases. The Myositis Association scientific symposium 2021.

18. Ancillary Studies in Myositis. NIAMS Rheumatology Didactics 2021.

19. Autoantibody-based classification in myositis. NIAMS Grand Rounds 2019.

20. Muscle MRI in diagnostics and assessment of myositis. ACR 2019.

21. Machine Learning on Myositis Transcriptomics (or How to Find a Needle in an RNA Haystack). NIAMS Grand Rounds 2019.

22. NIAMS Journal Club (2017-Now).

23. The interferon gene signature in dermatomyositis, the anti-synthetase syndrome, immune-mediated necrotizing myopathy, and inclusion body myositis: A comparative study. Global Conference on Myositis 2019 and NIAMS Grand Rounds 2019.

24. Grand rounds and teaching at St. Joseph´s Health Care. London (Ontario) 2018.

25. I Pinal-Fernandez, B Ferrer-Fabregas, E Trallero-Araguas, E Balada, MA Martinez, JC Milisenda, G Aparicio-Español, M Labrador-Horrillo, V Garcia-Patos, JM Grau-Junyent, A Selva-O’Callaghan. Tumor TIF1 Mutations and Loss of Heterozygosity Related to Cancer Associated Myositis. ACR 2017.

26. I Pinal-Fernandez, W Huang, M Casal-Dominguez, E Tiniakou, C Parks, K Pak, J Albayda, JJ Paik, DK Danoff, L Christopher-Stine, AL Mammen. Myositis Autoantibodies outperform clinical subgroup classification in predicting muscle weakness in myositis patients. EULAR 2017.

27. D Amici, I Pinal-Fernandez, D Mazala, T Lloyd, A Corse, L Christopher-Stine, A Mammen, E Chin. Calcium Dysregulation, Functional Calpainopathy, and Endoplasmic Reticulum Stress in Sporadic Inclusion Body Myositis. Global Conference on Myositis 2017.

28. R Yeker, I Pinal-Fernandez, T Kishi, IN Targoff, FW Miller, LG Rider, A Mammen. Anti-NT5C1A autoantibodies are frequent in juvenile myositis and associated with increased illness severity. Global Conference on Myositis 2017.

29. M. Alvarado-Cardenas, A. Marin, M.A. Martinez, I. Pinal-Fernandez, M. Labrador-Horrillo, P.J. Moreno, J.C. Millisenda, J.M. Grau, R. Pujol, C. Juárez, A. Selva-O’Callaghan Distinctive Immunofluorescence Pattern in Statin-Associated Autoimmune Myopathy with Anti-HMGCR Autoantibodies. EULAR 2016.

30. I Pinal-Fernandez, M Casal-Dominguez, A Lahouti, P Basharat, M Albayda, J Paik, S Ahlawat, S Danoff, T Lloyd, A Mammen, J Carrino, L Christopher-Stine. Thigh magnetic resonance imaging reveals increased active and chronic muscle damage in necrotizing myositis compared to polymyositis and dermatomyositis. EULAR 2016.

31. A. Fernández-Codina, I. Pinal-Fernández, I. De Torres-Ramírez, B. Pinilla, C. López, T. Rosiñol, M. Núñez-Fernández, F. Martínez-Valle. Update of the IgG4 Spanish registry after one year and a half. National Congress of the Spanish Society of Internal Medicine (SEMI) 2015.

32. Great Syndromes in Medicine. Translational Biomedical Research Master. Vall d’Hebron Reseach Institute (VHIR) and Autonomous University of Barcelona (2014).

33. Pinal-Fernandez I. Myositis activity measures. VII Autoimmune and Systemic Diseases National Meeting (2014).

34. Pinal-Fernandez I, Casciola-Rosen L, Christopher-Stine L, Corse A, Mammen A. Distinct Autoantibodies Associate with Specific Histological Abnormalities in Dermatomyositis. Myositis Study Group Meeting (2014).

35. Pinal-Fernandez I. Clinical Case. VI School of Internal Medicine for residents (2014).

36. Pinal-Fernandez I, Yagüe MI, Pecorelli R, Navarro A, Mellibovsky L. Cutaneous lesions and rapidly progressive pneumonitis. Parc de Salut MAR general sessions (2013).

37. Fernández-Codina A, Silveira M, Pinal Fernández I, Guillén del Castillo A, Simeón Aznar C, Fonollosa Plà V, Román Broto A, Vilardell Tarrés M. Lung transplantation in systemic sclerosis. Experience from a single reference center. XXXIV National Congress of the Spanish Society of Internal Medicine (SEMI 2013).

38. Fernández Viñas M, Pallisa Núñez E, Castella Fierro E, Pinal Fernández I, Andreu Soriano J, Gaete González J. Transthoracic echography and HRCT in the follow-up of lung disease due to systemic sclerosis. V national congress of Catalonian radiologists 2013

39. Armadans I, Selva O’Callaghan A, Visauta B, Pinal-Fernandez I, Juanós Iborra M, Cassá N, Guillén A, Vilardell Tarrés M. Well-being and quality of life in patients with inflammatory myopathy. 11th congress of the European Federation of Internal Medicine and XXXIII and National Congress of the Spanish Society of Internal Medicine (SEMI 2012)

40. Labirua A, Selva O’Callaghan A, Zock J, Orriols R, Martínez Gómez X, Juanós M, Pinal-Fernandez I, Vilardell M. Occupational exposures and clinical characteristics in patients with the antisynthetase syndrome. 11th Congress of the European Federation of Internal Medicine and XXXIII and National Congress of the Spanish Society of Internal Medicine (SEMI 2012)

41. Pinal Fernández I. NMR Determination of fat content in the thymus of C57BL / 6. Analysis of its variation with age. I Iberian Congress of Medical Students (CARES 2007)

42. Pinal Fernández I, Río Gómez A, Rodil Rodil V, Dosantos Carregal L. Predictors of Sudden Death and Heart Failure in Patients with Refractory Heart Failure. XII Congress of Cardiology for Students (CARES 2006)

43. Pinal Fernández I, Montes de Oca Pallas D. Anemia in mortality from heart failure. Coincidence or something more?. XI Congress of Cardiology for Students (CARES 2005).

POSTERS

1. Pinal-Fernandez I, Ruffer N, Casal-Dominguez M, et al. Specific Transcriptomic Profile Associated with Disease Activity in Muscle Biopsies from Patients with Sarcoid Myopathy. ACR 2024.

2. Pinal-Fernandez I, Reay D, Oriss T, Pak K, et al. Comparative Transcriptional Profiling Reveals Shared Pathway Activation Between Human Jo-1+ Anti-Synthetase Syndrome and Murine Histidyl-tRNA Synthetase-Induced Myositis. ACR 2024.

3. Kirou R, Pinal-Fernandez I, and Andrew Mammen. Distinct Cytokine and Cytokine Receptor Expression Patterns Characterize Different Subtypes of Inflammatory Myopathies. ACR 2024.

4. Zhang Y, Ross B, Galvan1 D, Bao Y, Matsuda D, Grosskurth S, Iago Pinal-Fernandez, et al. Effective Engineering of CD8+ T Cells from Autoimmune Disease Patients Utilizing a CD8-Targeted Lipid NanoparticleEncoding an Anti-CD19 CAR mRNA(CPTX2309). ACR 2024.

5. Casal-Dominguez M, Pinal-Fernandez I, Muñoz-braceras S, et al. Antisynthetase Autoantibodies Disrupt the Function of Their Target Aminoacyl-tRNA Synthetases in Muscle Cells. ACR 2024.

6. Musai J, Jayaraman S, Pak K, Pinal-Fernandez I, et al. Anti-Mi2 Autoantibodies in Dermatomyositis Patients Also Recognize Autoimmune Regulator (AIRE) Protein. ACR 2024.

7. Casal-Dominguez M, Milisenda J, Pinal-Fernandez I, et al. Transcriptomic profiles in muscle biopsies from systemic sclerosis patients with different autoantibodies. 5th Global Conference on Myositis 2024.

8. Gil-Vila A, Moreno-Cardenas AB, …, Pinal-Fernandez I, …, et al. Tumors from cancer-associated myositis harbor genetic events in myositis-specific autoantigens. 5th Global Conference on Myositis 2024.

9. Milisenda J, Pinal-Fernandez I, Pak K, et al.Lipid droplets in immune-mediated necrotizing myositis. 5th Global Conference on Myositis 2024.

10. Muñoz-Braceras S, Pinal-Fernandez I, Casal-Dominguez, et al. Myositis-specific autoantibodies induce distinct transcriptomic signatures in human skeletal muscle myoblasts. 5th Global Conference on Myositis 2024.

11. Musai J, Jayaraman S, Pak K, Pinal-Fernandez I, et al. Autoantibodies recognizing AIRE detected in anti-Mi2-positive dermatomyositis. 5th Global Conference on Myositis 2024.

12. Ogbonnaya-Whittlesey SA, Pinal-Fernandez I, Mammen AL. Fascial thickness in inflammatory myopathies. 5th Global Conference on Myositis 2024.

13. Milisenda J, Pinal-Fernandez I, Pak K, et al. Muscle pathology in patients with primary biliary cholangitis. 5th Global Conference on Myositis 2024.

14. Najjar R, Pinal-Fernandez I, Mammen AL, et al. Alternative Splicing and Expected Protein Changes in Muscle Biopsies from Different Types of Idiopathic Inflammatory Myopathies. ACR 2023.

15. Casal-Dominguez M, Milisenda JC, Pinal-Fernandez I, et al. Transcriptomic Profiles in Muscle Biopsies from Systemic Sclerosis Patients with Different Autoantibodies. ACR 2023.

16. Sherman M, Noroozi Farhad P, Trieu E, …, Pinal-Fernandez I, …, et al. Anti-PM/Scl Autoantibodies in Juvenile Myositis Are Associated with a Distinct Phenotype Resembling Anti-synthetase Syndrome. ACR 2023.

17. Milisenda JC, Pinal-Fernandez I, Pak K, et al. Muscle Pathology in Patients with Primary Biliary Cholangitis. ACR 2023.

18. M Casal-Dominguez, I Pinal-Fernandez, K Pak, et al. RNA-sequencing of the complement genes in the muscle biopsies of autoimmune myopathies. 4th Global Conference on Myositis 2022.

19. S Munoz-Braceras, I Pinal-Fernandez, M Casal-Dominguez, et al. Analysis of miRNA expression profiles of myositis subgroups in muscle biopsies. 4th Global Conference on Myositis 2022 and NIAMS IRP Scientific Retreat 2019.

20. J Torres-Ruiz, K Pak, I Pinal-Fernández, et al. Spatial transcriptomic analysis of dermatomyositis muscle unveils a unique signature in atrophic perifascicular muscle fibers. 4th Global Conference on Myositis 2022.

21. J Ros, A Gil-Vila, J Lostes, P Nuciforo, C Vilaplana, E Trallero-Araguás, I Pinal-Fernandez, et al. Immunogenetics features of dermatomyositis-associated malignancies. 4th Global Conference on Myositis 2022.

22. MA Sherman, R Graf, AS Galindo-Feria, SE Sabbagh, I Pinal-Fernandez, et al. Anti-FHL1 autoantibodies in juvenile myositis are associated with myositis-associated autoantibodies but not distinctive clinical features. 4th Global Conference on Myositis 2022.

23. JC Milisenda, I Pinal-Fernandez, TE Lloyd, et al. The Pattern of Major Histocompatibility Complex Class I Expression in Muscle Biopsies from Patients with Different Types of Myositis and other Neuromuscular Disorders. 4th Global Conference on Myositis 2022.

24. C Zhao, M Mule, A Martins, I Pinal-Fernandez, et al. 540 Baseline mTOR transcriptional signatures in CD8 T cells are associated with immune-related adverse events but not anti-tumor responses in patients receiving immune checkpoint inhibitors. 36 Annual Meeting of the The Society for Immunotherapy of Cancer 2021.

25. M Casal-Dominguez, I Pinal-Fernandez, A Mammen. Local complement overexpression in the muscle biopsies of patients with inflammatory myopathies. NIAMS IRP Scientific Retreat 2021.

26. Sabbagh S, Pinal-Fernandez I, Casal-Dominguez M, et al. Anti-mitochondrial Autoantibodies Are Associated with Cardiomyopathy, Dysphagia, and Features of More Severe Disease in Adult-onset Myositis. ACR 2020.

27. Pinal-Fernandez I, Pak K, Gil-Vila A, et al. Anti-cortactin Autoantibodies Are Associated with Key Clinical Features in Adult Myositis but Are Rarely Present in Juvenile Myositis. ACR 2020.

28. Sabbagh S, Neely J, Chow A, …, Pinal-Fernandez I, et al. Risk Factors Associated with Pneumocystis Jirovecii Pneumonia in Juvenile Myositis in North America. ACR 2020.

29. Sabbagh S, Pinal-Fernandez I, Casal-Dominguez M, et al. Anti-Mitochondrial Autoantibodies Are Associated with Dysphagia in Juvenile and Adult Myositis, and with Persistent Weakness and Cardiomyopathy in Adult Myositis. ACR 2020.

30. M Casal-Dominguez, I Pinal-Fernandez, K Pak, et al. Autoantibodies outperform the ACR/EULAR classificatory myositis criteria in adult myositis patients. NIAMS IRP Scientific Retreat 2020.

31. I Pinal-Fernandez, M Casal-Dominguez, Assia Derfoul, et al. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis. NIAMS IRP Scientific Retreat 2020.

32. I Pinal-Fernandez, M Casal-Dominguez, A Derfoul, et al. Identification of Distinctive Interferon Gene Signatures in Different Types of Inflammatory Myopathy. ACR 2019.

33. M Casal-Dominguez, I Pinal-Fernandez, A Marin, et al. Frequency and Staining Patterns of Antinuclear Antibodies in Myositis Patients Without Known Myositis-specific Autoantibodies. ACR 2019.

34. S Sabbagh, I Pinal-Fernandez, M Casal-Dominguez, et al. Anti-mitochondrial Autoantibodies in Idiopathic Inflammatory Myopathies. ACR 2019.

35. A Fernandez-Codina, B Pinilla, I Pinal-Fernandez, et al. Use of the provisional EULAR/ACR Igg4-RD classification criteria in a cohort of Spanish patients. EULAR 2019.

36. B Kisluk, J Milisenda, I Pinal-Fernandez, et al. Muscle involvement in systemic sclerosis. EULAR 2019.

37. I Pinal-Fernandez, M Casal-Dominguez, A Derfoul, et al. The interferon gene signature in dermatomyositis, the anti-synthetase syndrome, immune-mediated necrotizing myopathy, and inclusion body myositis: A comparative study. NIAMS IRP Scientific Retreat 2019.

38. I Pinal-Fernandez, K Pak, M Casal-Dominguez, et al. Validation of anti-Mi2 autoantibody testing by line blot. NIAMS IRP Scientific Retreat 2019.

39. J Milisenda, I Pinal-Fernandez, T. Lloyd, et al. The prevalence of p62 immunostaining in muscle biopsies from patients with myositis, non-inflammatory myopathies, and neurogenic disorders. Global Conference on Myositis 2019

40. I Pinal-Fernandez, D Amici, C Parks, et al. Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity. Global Conference on Myositis 2019

41. J Ros, J Lostes, P Nuciforo, C Viaplana, J Milisenda, E Trallero-Araguas, I Pinal-Fernandez et al. Tumour Infiltrating Lymphocytes quantification in Cancer-Associated Dermatomyositis. Global Conference on Myositis 2019

42. A Gil-Vila, E Trallero-Araguas, M Alvarado-Cardenas, I Pinal-Fernandez, et al. Reliability of PET/TC cancer screening in a large cohort of patients diagnosed with idiopathic inflammatory myopathy. Global Conference on Myositis 2019

43. I Pinal-Fernandez, K. Pak, M. Casal-Dominguez, W. Huang, J. Albayda, E. Tiniakou, J.J. Paik, C.A. Mecoli, S.K. Danoff, L. Christopher-Stine, A.L. Mammen. Longitudinal Course of the Disease in Anti-Mi2 Patients: More Intense Muscle Weakness, Good Response to Treatment and Progressive Reduction of Autoantibody Titers. ACR 2018 and NIAMS IRP Scientific Retreat 2019

44. S. Sabbagh, I. Pinal-Fernandez, T Kishi, I.N. Targoff, F.W. Miller, L.G. Rider, A. Mammen. Association of Anti-Ro52 Autoantibodies with Interstitial Lung Disease and More Severe Disease Manifestations in Juvenile Idiopathic Inflammatory Myopathies. ACR 2018, Global Conference on Myositis 2019 and NIAMS IRP Scientific Retreat 2019

45. Y. Hosono, I. Pinal-Fernandez, K. Pak, J. Albayda, E. Tiniakou, J.J. Paik, C.A. Mecoli, S.K. Danoff, L. Christopher-Stine, A. Mammen. Anti-Splicing Factor Proline/Glutamine-Richautoantibodies Rarely Co-Exist with Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies in a Cohort of Dermatomyositis Patients from the United States. ACR 2018

46. D. Amici, I. Pinal-Fernandez, R. Pagkatipunan, A. Mears, R. De Lorenzo, E. Tiniakou, J Albayda, J.J. Paik, T. Lloyd, L. Christopher-Stine, A. Mammen, Tae Chung. Muscle Endurance Deficits in Myositis Patients Despite Normal Manual Muscle Testing Scores. ACR 2018

47. M. Casal-Dominguez, I. Pinal-Fernandez, A. Corse, JJ. Paik, J. Albayda, L. Casciola-Rosen, C. Johnson, S. Danoff, L. Christopher-Stine, E. Tiniakou, A. Mammen. Myositis Patients with Anti-U1-RNP and Anti-Ro52 Autoantibodies Are at Risk of Pericarditis, Glomerulonephritis, and Pulmonary Hypertension. ACR 2018

48. C. Johnson, R. McKibben, I. Pinal Fernandez, K. Psoter, J. Paik, M. Albayda, C. Mecoli, E. Tiniakou, A. Mammen, L. Christopher-Stine, S.K. Danoff. The ILD-GAP Risk Prediction Model Performs Poorly in Patients with Myositis-Associated ILD. ATS 2018

49. R De Lorenzo, I Pinal-Fernandez, M Casal-Dominguez, W Huang, JC Milisenda, C Parks, K Pak, C Johnson, E Tiniakou, J Albayda, JJ Paik, SK Danoff, L Christopher-Stine, A Corse, A Mammen. Longitudinal cohort study of anti-PM/Scl myositis patients: mild muscle and lung involvement with prominent perivascular inflammation. ACR 2017

50. M Casal-Dominguez, I Pinal-Fernandez, C Johnson, A Mammen, J Albayda, J Huapaya, L Christopher-Stine, SK Danoff, LL Silhan, JJ Paik. Efficacy and Adverse Effects of Methotrexate Compared with Azathioprine in the Antisynthetase Syndrome. Global Conference on Myositis 2017.

51. I Pinal-Fernandez, W Huang, M Casal-Dominguez, E Tiniakou, C Parks, K Pak, J Albayda, JJ Paik, SK Danoff, L Christopher-Stine, AL Mammen. Myositis Autoantibodies outperform clinical subgroup classification in predicting muscle weakness in myositis patients. Global Conference on Myositis 2017 and NIAMS IRP Scientific Retreat 2017.

52. C Parks, I Pinal-Fernandez, M Casal-Dominguez, J Albayda, JJ Paik, SK Danoff, L Christopher-Stine, L Casciola-Rosen, AL Mammen. Activity of Autoantibody Titers Against SRP Subunits and SRP RNA in Anti-SRP–associated Myopathy. Global Conference on Myositis 2017 and NIAMS IRP Scientific Retreat 2017.

53. A Fernandez-Codina, I Pinal-Fernandez, B Pinilla, C Lopez, R Solans-Laque, G Fraile-Rodriguez, E Fonseca- Aizpuru, JM Cameselle-Tejeiro, S Prieto-Gonzalez, J Pardos-Gea, J Gil, T Rossinyol, MJ Nuñez-Fernandez, G Salvador-Cervello, F Martinez-Valle. Treatment and outcomes in Spanish patients with IgG4-related disease. EULAR 2017.

54. R Yeker, I Pinal-Fernandez, T Kishi, IN Targoff, FW Miller, LG Rider, A Mammen. Anti-NT5C1A autoantibodies are frequent in juvenile myositis and associated with increased illness severity. EULAR 2017, ACR 2017 and NIAMS IRP Scientific Retreat 2017.

55. A Redondo-Benito, A Curran-Fabregas, A Villar-Gomez, E Trallero-Araguas, A Fernandez-Codina, I Pinal-Fernandez, A Selva-O´Callaghan. Opportunistic infections in patients with myositis. A retrospective cohort study. EULAR 2017.

56. I Pinal-Fernandez, M Casal-Dominguez, JA. Carrino, A Lahoutiharahdashti, P Basharat, J Albayda, JJ Paik, S Ahlawat, SK Danoff, TE Lloyd, A Mammen, L Christopher-Stine. Thigh Muscle MRI Reveals Extensive Muscle Edema and Early Fatty Replacement in Patients with Immune-Mediated Necrotizing Myopathy. ACR 2016.

57. A Fernández-Codina, I Pinal-Fernández, O Orozco-Gálvez, R Solans-Laqué, S Bujan-Rivas, V Fonollosa-Plà, M Vilardell-Tarrés, F Martínez-Valle. Use of disease-modifying anti-rheumatic drugs in a cohort of patients with IgG4-related disease. EULAR 2016.

58. E Tiniakou, I Pinal Fernandez, L Christopher-Stine, J Werner, T Lloyd, J Paik, J Albayda, S Danoff, A Mammen. Slow recovery of muscle strength in young anti-HMG-CoA reductase positive myopathy patients. EULAR meeting 2016.

59. I Pinal-Fernandez, C Parks, E Tiniakou, M Albayda, J Paik, A Lahouti, M Casal-Dominguez, K Pak, W Huang, TE Lloyd, S Danoff, L Casciola-Rosen, L Christopher-Stine, AL Mammen. Anti-SRP-associated autoimmune myopathy: younger age at onset is associated with more severe disease and worse outcome. EULAR 2016, Global Conference on Myositis 2017 and NIAMS IRP Scientific Retreat 2017.

60. H. Ilieva, I. Pinal Fernandez, P. Natov, E. Mosmiller, L. Clawson, E. Simpson, S. Appel, N Maragakis. Earlier Disease Onset in Non-Caucasian Amyotrophic Lateral Sclerosis (ALS) Patients: Retrospective Analysis from Two Tertiary Centers. American Academy of Neurology Meeting 2016.

61. A. Lahoutiharahdashti, I. Pinal-Fernandez, J. Albayda, J.J. Paik, S.K. Danoff, A. Mammen, L. Christopher-Stine. Autoimmune Myopathies: Effects of Intravenous Immunoglobulin Therapy on Muscle Strength and Predictors of Response. ACR/ARHP Meeting 2015.

62. M. Albayda, I. Pinal-Fernandez, L. Christopher-Stine, S.K. Danoff, C. Johnson, C. Mecoli, J.J. Paik, A. Ramji, A. Mammen. Subcutaneous Edema, Distal Weakness and Dysphagia Associated with the NXP2 Antibody. ACR/ARHP Meeting 2015.

63. E. Tiniakou, I. Pinal-Fernandez, L. Christopher-Stine, J. Werner, T. E. Lloyd5, J.J. Paik, J. Albayda, S.K. Danoff, A. Mammen. Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Positive Myopathy Patients without Statin Exposure May Have a Progressive Disease That Worsens Despite Aggressive Immunosuppressive Therapy. ACR/ARHP Meeting 2015.

64. A. Fernández-Codina, I. Pinal-Fernández, O. Orozco-Gálvez, R. Solans-Laqué, S. Buján-Rivas, M. Vilardell-Tarrés, F. Martínez-Valle. Use of disease-modifying antirheumatic drugs in a cohort of patients with IgG4 related disease. National Congress of the Spanish Society of Internal Medicine (SEMI) 2015

65. P. Basharat, A Lahouti H., A.L. Mammen, I. Pinal-Fernandez, T Bichile, T. E. Lloyd, S.K. Danoff, L. Casciola-Rosen, L Christopher-Stine. Diabetes and Atorvastatin Are Potential Risk Factors for Statin-Associated Myopathy with Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase. ACR/ARHP Meeting 2014

66. T.E. Lloyd, I.Pinal-Fernandez, L. Christopher-Stine, J.S. Mammen, A.L. Mammen. Overlapping features of inclusion body myositis (IBM) and polymyositis (PM) in human immunodeficiency virus (HIV)-infected patients. Myositis Study Group Meeting 2014

67. Johnson C, Pinal-Fernandez I, Paik J, Albayda J, Mammen AL, Christopher-Stine L, et al. Assessment Of Mortality In Autoimmune Myositis With And Without Associated Interstitial Lung Disease. American Thoracic Society Congress; 2014.

68. I Pinal-Fernandez, V Pineda-Sanchez, E Pallisa Núñez, CP Simeón-Aznar, A Selva-O´Callaghan. Comparison of fast 1.5t chest MRI with HRCT scan in the assessment of interstitial lung disease extension secondary to systemic sclerosis. EULAR congress 2014.

69. I Pinal-Fernandez, A Selva-O’Callaghan, A Fernandez-Codina, X Martinez-Gomez, J Angel Rodrigo-Pendas, J Perez-Lopez, M Vilardell-Tarres. Pregnancy in adult-onset idiopathic inflammatory myopathy. Report from a cohort of myositis patients from a single center. EULAR congress 2014.

70. I Pinal-Fernandez, M Del Grande, F Del Grande, J Carrino, A Mammen, T Lloyd, L Christopher-Stine. Association between muscle enzymes, acute-phase reactants and MRI findings in myositis. EULAR congress 2014.

71. I Pinal-Fernandez, L Christopher-Stine, L Casciola-Rosen, A Corse, A Mammen. Correlating muscle biopsy features with autoantibodies in patients with dermatomyositis and the jo-1 antisynthetase syndrome. EULAR congress 2014.

72. I. Pinal Fernández, A. Selva OCallaghan, A. Codina, J. Rodrigo Pendas, X. Martínez Gómez, M. Juanós Iborra, J. Pérez López, M. Vilardell Tarrés. Idiopathic inflammatory myopathy and pregnancy. XXXIV National Congress of the Spanish Society of Internal Medicine (SEMI) 2013

73. I. Pinal Fernández, C. Simeón Aznar, A. Selva OCallaghan, E. Pallisa Núñez, V. Pineda, A. Fernández Codina, V. Fonollosa Plà, M. Vilardell Tarrés. Correlation between nuclear magnetic resonance and HRCT for the study of the interstitial lung disease due to systemic sclerosis. XXXIV National Congress of the Spanish Society of Internal Medicine (SEMI) 2013

74. J. Perez-Lopez, A. Selva-O’Callaghan J. C. Milisenda, L. Gallego, E. Trallero-Araguas, M. Juanos-Iborra, I. Pinal, J. M. Grau-Junyent, M. Vilardell-Tarrés. Adult Pompe’s disease: screening in patients with myopathies of unknown etiology. EULAR congress 2013

75. A. Labirua Iturburu, A. Selva O’Callaghan, X. Martínez Gómez, E. Trallero Araguás, M. Juanós Iborra, I. Pinal, M. Labrador Horrillo, M. Vilardell Tarrés. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. An observational study. 11th Congress of the European Federation of Internal Medicine and XXXIII and National Congress of the Spanish Society of Internal Medicine (SEMI) 2012

76. Usefulness of thoracic echography in patients affected by antisynthetase syndrome. XXXII National Congress of the Spanish Society of Internal Medicine (SEMI) and XIV Congress of the Canarian Society of Internal Medicine 2011

77. Pinal-Fernández I, Pallisa-Nuñez E, Castella Fierro E, Martínez-Gómez X, Simeon Aznar C, Muñoz Gall X, Sureda D, Selva O´Callaghan A.

78. Pinal-Fernández I, Mayorga-Gomez L, Gallardo-Jimenez P. Achromobacter xylosoxidans-infection. XV National Congress of the Spanish Society of Clinical Microbiology and Infectious Diseases 2011

79. Pinal-Fernández I, Segura-García A. Tolvaptan in the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) secondary to treatment with citalopram. XXII Congress of the Valencian Society of Endocrinology and Nutrition 2010 and XIV Congress of the Catalanobalearian Society of Internal Medicine 2011

80. Pinal-Fernández I. Humoral hypercalcemia secondary-mixed endometrial carcinoma. XXII Congress of the Valencian Society of Endocrinology and Nutrition 2010

81. Pinal-Fernández I, Portela M. Diabetes insipidus secondary-AML M2 trilinear dysplasia, deletion of chromosome 7 and 3q21:q26 inversion. XXII Congress of the Valencian Society of Endocrinology and Nutrition 2010

82. Pinal-Fernandez I, Martin-Pastor M, Bravo S, Ferro Gallego P, Lago-Leston R, Alvarez C, Domínguez-Gerpe ML. Metabolomic profiles of hydrophilic and lipophilic extracts from thyroid cell line and Pathological Tissues normal by 1H NMR spectroscopy. 34 Congress of the Federation of European Biochemical Societies (FEBS) 2009

83. Ferro-Gallego P, Lago-Leston A, Pinal-Fernández I, Castro-Gago M and Domínguez-Gerpe ML. New case: a female patient in the mosaicism With A SLC16A2 gene encoding the thyroid hormone specific transporter monocarboxylate transporter 8 (MCT8). 34 Congress of the Federation of European Biochemical Societies (FEBS) 2009

84. Pinal-Fernández I, Martín-Pastor M, Lado-Abeal J, Araujo-Vilar D, Domínguez-Gerpe ML. NMR / MRI study of the age-associated Involution of the thymus in C57BL / 6 mice. I Iberian Meeting of NMR 2008

85. Pinal-Fernández I, Ferro-Gallego P, Martín-Pastor M, Dominguez Gerpe ML. Quantitative and Qualitative Changes in the thymus cellularity of mice With Age Determined by NMR spectroscopy. 33 Congress of the Federation of European Biochemical Societies (FEBS) and 11 International Congress of Biochemistry and Molecular Biology (IUMBM) 2008

86. Iglesias Fungueiro MJ, Viéitez Rodríguez O, Pinal Fernández I, et al. Influence of the S33P polymorphism of monocarboxylates 8 (MCT8) on serum TSH and thyroid hormones in a population of healthy male volunteers of Galicia. 48 National Congress of the Spanish Society of Endocrinology and Nutrition 2006

CONFERENCES AND COURSES

1. International Annual Patient Conference of the Myositis Association (2024)

2. 15e Journée Interdisciplinaire du Muscle Inflammatoire (JIMI, 2024)

3. Global Conference on Myositis (2015, 2017, 2022, 2024)

4. NIAMS IRP Scientific Retreat (2016-2024)

5. 23rd Annual Neuromuscular Study Group Scientific Meeting (2022)

6. 13^th International Congress on Autoimmunity (2022)

7. ACR/ARHP Annual Meeting (2016-23)

8. 2018 Update on Juvenile Myositis Care and Research (The George Washington University School of Medicine and Public Health 2018)

9. Advanced Studies in Bioinformatics and Data Science (Foundation for Advanced Education in the Sciences, National Institutes of Health, 2015-2018):

   1. Introduction to New Technologies in Data Science 2018

   2. Theoretical and Applied Bioinformatics 2017

   3. Super R with Shiny 2017

   4. Machine Learning and Object-Oriented Programming with Python 2016

   5. Bioinformatics for Analysis of Data Generated by Next Generation Sequencing 2016

   6. Introduction to Python 2015

10. Medium level certificate of competencies in information and communication technologies (UOC 2016-17).

11. EULAR Congress (2013, 2014, 2016, 2017)

12. Completion of the NIH Clinical Research Curriculum Certificate (2017)

13. XXXVIII National Congress of the Spanish Society of Internal Medicine (2016)

14. Introduction to the Principles and Practice of Clinical Research 2016 (National Institutes of Health Clinical Center)

15. VII Autoimmune and Systemic Diseases National Meeting (2014)

16. Myositis Study Group Meeting (2014)

17. VI School of Internal Medicine for Residents (2014)

18. 2nd ESF-Sponsored International Myositis Genetics Workshop (2014)

19. Scientific redaction and publication (Ibero-American Nature Publishing Group) (2013)

20. Seminar of Clinical Research of the European Federation of Internal Medicine (2013)

21. 3rd European School of Internal Medicine (2013)

22. 11th Congress of the European Federation of Internal Medicine and XXXIII National Congress of the Spanish Society of Internal Medicine (2012)

23. V Autoimmune and Systemic Diseases National Meeting (2012)

24. VI Actualization National Meeting for Residents in Autoimmune and Systemic Diseases (2012)

25. V National Update Meeting in Autoimmune and Systemic Diseases for Residents of the La Paz University Hospital (2011)

26. XXXII National Congress of the Spanish Society of Internal Medicine (SEMI) and XIV Congress of the Canarian Society of Internal Medicine (2011)

27. XV National Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology (2011)

28. Course of Advanced Life Support for Adults of the Catalan Resuscitation Council/European Resuscitation Council (Barcelona 2011)

29. XIV Congress of the Catalano-Balearic Internal Medicine Society (2011)

30. 5th Update on Autoimmune Diseases (Barcelona 2010)

31. XXII Congress of the Endocrinology and Nutrition Society of Valencia (2010)

32. La Paz University Hospital (2010)

33. II Update Workshop in Systemic and Autoimmune Diseases of the

34. VI Update on Infectious Diseases of the La Paz University Hospital (2010)

35. XCII Course of Digestive Pathology of the Santa Creu and San Pau Hospital (2009)

36. SAP navigation (2009)

37. Hospitalization SAP course for physicians (2009)

38. Emergency SAP course for physicians (2009)

39. Ambulatory SAP course for physicians (2009)

40. Immersion program of the Vall d’Hebron University Hospital (2009)

41. III Congress of the Spanish Society of Pharmacogenetics and Pharmacogenomics (2007)

42. I Iberian Congress of Medical Students (CARES 2007).

43. Course of Introduction to Research in Biochemistry and Molecular Biology of the Spanish Society of Biochemistry and Molecular Biology (SEBBM) and Department of Biochemistry and Molecular Biology, University of Málaga

44. XXX Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM)

45. Applications of Magnetic Resonance to Biomedical Sciences. Rede de Infraestructuras de Apoio á Investigación e ó Desenvolvemento Tecnolóxico (RIADT) 2007

46. Confocal Microscopy Course and its Applications. Rede de Infraestructuras de Apoio á Investigación e ó Desenvolvemento Tecnolóxico (RIADT) 2007

47. XII Congress of Cardiology for Students (CARES 2006)

48. XI Congress of Cardiology for Students (CARES 2005)

SCHOLARSHIPS, GRANTS, AND AWARDS:

1. 2023 NIAMS Director’s Group Award as part of the NIAMS Myositis Group

2. 2022 NIAMS Director’s Group Award as part of the COVID-19 Systemic Autoimmunity Team

3. The Mosaic of Autoimmunity Award 2022

4. Fellowship to attend the 2019 Global Conference on Myositis meeting

5. Extraordinary doctorate award of the Open University of Barcelona 2020

6. Award for the best poster: Myositis autoantibodies outperform clinical subgroup classification in predicting muscle weakness in myositis patients. NIAMS IRP Scientific Retreat 2017

7. Travel bursary for EULAR Congress (2014, 2017)

8. Best Young Internist Award of the Spanish Society of Internal Medicine (SEMI) 2016

9. Myositis Association Fellowship Award 2016

10. Extraordinary doctorate award of the Autonomous University of Barcelona 2016

11. Award for the best oral communication: Statin-associated autoimmune myopathy: description of a characteristic immunofluorescent pattern and its correlation with anti-HMGCR autoantibodies. XVI Congress of the Catalano-Balear Society of Internal Medicine 2016

12. Award for the best oral communication: Update of the IgG4 Spanish registry after one year and a half. National Congress of the Spanish Society of Internal Medicine (SEMI) 2015

13. Rio Hortega Postdoctoral Fellowship Award from the Spanish Ministry of Economy and Competitiveness (2015).

14. Joan Vivancos award for the best article published during 2014 (“Pregnancy in adult-onset idiopathic inflammatory myopathy: Report from a cohort of myositis patients from a single center”). Academy of Medical Sciences of Catalonia and the Balearic Islands and the Catalonian-Balearic Society of Internal Medicine.

15. Grant to attend the VI School of Internal Medicine for residents 2014.

16. Grant to attend the Seminar of Clinical Research of the European Federation of Internal Medicine 2013

17. Grant to attend the 3rd European School of Internal Medicine 2013

18. CTO Award 2011 for the best research project conducted by a hospital resident

19. Postgraduate Research Fellowship Award of Xunta de Galicia (2008-2009)

20. Scholarship of the Ministry of Education and Science for the Collaboration with the Department of Medicine (2007/2008)

21. CTO Award 2007 for the best complementary development to the medical education for medical students

22. Award for the best oral communication: NMR Determination of fat content in the thymus of C57BL / 6. Analysis of its variation with age. I Iberian Congress of Medical Students (CibeMe 2007)

23. Conferences, symposia, and seminars grant for university students. Xunta de Galicia (2006)

24. Award for the best oral communication: Predictors of Sudden Death and Heart Failure in Patients with Refractory Heart Failure. XII Cardiology Students Congress (CARES 2006)

RESEARCH PROTOCOLS

1. 000894-AR: Natural History of Inflammatory Muscle Diseases Associate Investigator NIAMS/NIH Bethesda, United States of America 2023-Present

2. 01-AR-0227 (NCT00024479): Studies of the Natural History of Rheumatic Disease in Minority Communities. Associate Investigator NIAMS/NIH Bethesda, United States of America 2022-Present

3. 000207-AR (NCT04690816): The Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases; An Observational Prospective Study. Associate Investigator NIAMS/NIH Bethesda, United States of America 2022-Present

4. 91-AR-0196 (NCT00001265): Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis and Related Diseases.
   Associate Investigator NIAMS/NIH Bethesda, United States of America 2018-2024

5. NIH study RA101495-02.202 (NCT04025632): Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy. Associate Investigator NIAMS/NIH Bethesda, United States of America
   2019-2020

6. NIH study 04-C-0281 (NCT00092235): Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease. Collaborator NIAMS/NIH Bethesda, United States of America 2019-Present

7. NIH study MSB0010718C (NCT01772004): Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor). Collaborator NIAMS/NIH Bethesda, United States of America 2019-Present

8. Hopkins study NA_00007454: Development of a Research Database of Myositis Patients.
   Co-Investigator Johns Hopkins University Baltimore, United States of America 2013-Present

9. Hopkins study IRB00235256: Myositis Research Registry. Co-Investigator Johns Hopkins University Baltimore, United States of America 2020-Present

10. Hopkins study IRB00075085: Development of a questionnaire database for Myositis Patients. Co-Investigator Johns Hopkins University Baltimore, United States of America 2015-2020

11. Hopkins study IRB00169980: The Link Between Nailbed Capillaroscopy and Cerebrovascular Disease. Co-Investigator Johns Hopkins University Baltimore, United States of America 2018-2019

12. Hopkins study NA_00018091: Neuromuscular Clinic Patient Registry.
    Co-Investigator Johns Hopkins University Baltimore, United States of America 2015-2020

13. Hopkins study NA_00034985: Clinical Epidemiology of Lung Disease and Other Features of Scleroderma and Other Connective Tissue Diseases. Co-Investigator Johns Hopkins University Baltimore, United States of America 2016-Present

14. Hopkins study NA_00081989 A single center experience of using rituximab for treatment of granulomatosis with polyangiitis and microscopic polyangiitis. Co-Investigator Johns Hopkins University Baltimore, United States of America 2013

15. FIS grant (PI18/01609): Tumor-infiltrating lymphocytes and cancer-associated dermatomyositis.
    Collaborator Vall d’Hebron Hospital Barcelona-Spain 2018-Present

16. FIS grant (PI15/02100): Identification of new antigens in patients with inflammatory myopathy. Co-Investigator Vall d’Hebron Hospital Barcelona-Spain 2015-2018

PEER-REVIEW ACTIVITIES

• Assistant Editor for Frontiers in Immunology (2022-2024)

• Review Editor for Frontiers in Immunology (2021-2022)

• Section Editor for Current Treatment Options in Rheumatology (2020-2022)

• Reviewer for Cancer Research UK grant applications

• Reviewer for journals:

  • ACR meeting 2020 (Myositis/Myopathies Abstract Review Committee)
  • Acta Dermato-Venereologica
  • Annals of Internal Medicine
  • Annals of the Rheumatic Diseases
  • Archivos de Medicina
  • Arthritis & Rheumatology
  • Arthritis Care & Research
  • BMC Rheumatology
  • BMJ Case Reports
  • European Journal of Neurology
  • European Radiology
  • Experimental Neurology
  • Frontiers in Immunology
  • Frontiers in Genetics of Common and Rare Diseases
  • Journal of Clinical Laboratory Analysis
  • Journal of Musculoskeletal Pain
  • Journal of Rheumatology
  • Journal of Thoracic Disease
  • Journal of the Neurological Sciences
  • Journal of Neuromuscular Diseases
  • Lancet
  • Life Sciences
  • Medical Science Monitor
  • Medicina Clínica
  • Muscle and Nerve
  • Neuroimmunology and Neuroinflammation
  • Neurology
  • Neuropathology and Applied Neurobiology
  • Neuromuscular Disorders
  • Oxford Medical Case Reports
  • RMD Open Rheumatic & Musculoskeletal Diseases
  • Rheumatology
  • Rheumatology and Therapy
  • Scandinavian Journal of Immunology
  • Seminars in Arthritis and Rheumatism

COLLABORATION WITH PHARMACEUTICAL COMPANIES

• Otsuka Pharmaceutical advisory consultant (2012)

MEMBERSHIP IN SCIENTIFIC ASSOCIATIONS

• Member of the Scientific Committee for the Journée Interdisciplinaire du Muscle Inflammatoire (JIMI) (from 2024)

• Cutaneous Chronic GVHD Task Force Planning Meeting (2024)

• Member of the International Myositis Assessment and Clinical Studies Group Scientific Committee (2019-2020, 2023-Present)

• Myositis Assessment and Clinical Studies Group (from 2019)

• American College of Rheumatology (from 2018)

• European Society of Internal Medicine (from 2010)

• Health and Medical Sciences Academy of Catalonia and the Balearic Islands (from 2010)

• Spanish Society of Internal Medicine (from 2010)

• Catalonian-Balearic Society of Internal Medicine (from 2010)

LANGUAGES

	Speech	Reading	Writing
English	Good	Good	Good
Spanish	Good	Good	Good
Galician	Good	Good	Good